189 related articles for article (PubMed ID: 38374336)
1. Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines.
Wu Y; Wang V; Yarchoan R
Sci Rep; 2024 Feb; 14(1):4125. PubMed ID: 38374336
[TBL] [Abstract][Full Text] [Related]
2. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
4. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R
AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183
[TBL] [Abstract][Full Text] [Related]
5. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
[TBL] [Abstract][Full Text] [Related]
6. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
7. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
8. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract][Full Text] [Related]
9. KSHV/HHV8-associated lymphoproliferations in the AIDS setting.
Schulz TF
Eur J Cancer; 2001 Jul; 37(10):1217-26. PubMed ID: 11423254
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system.
Lopez M; Kainthla R; Lazarte S; Chen W; Nijhawan AE; Knights S
Eur J Haematol; 2024 May; 112(5):723-730. PubMed ID: 38155405
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
12. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
[TBL] [Abstract][Full Text] [Related]
13. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
14. SUMO Modification of Histone Demethylase KDM4A in Kaposi's Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Yeh WW; Chen YQ; Yang WS; Hong YC; Kao S; Liu TT; Chen TW; Chang L; Chang PC
J Virol; 2022 Aug; 96(16):e0075522. PubMed ID: 35914074
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
16. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
[TBL] [Abstract][Full Text] [Related]
17. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.
Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q
J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572
[TBL] [Abstract][Full Text] [Related]
18. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
Ma Z; Hopcraft SE; Yang F; Petrucelli A; Guo H; Ting JP; Dittmer DP; Damania B
PLoS Pathog; 2017 May; 13(5):e1006350. PubMed ID: 28459883
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
20. Linking KSHV to human cancer.
Wong EL; Damania B
Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
